Nurse washing patient with Antiseptic gloves impregnated with 2% chlorhexidine digluconate to remove bacteria

Universal decolonization

with 2% Chlorhexidine

Digluconate (CHG)

Swash away the harmful bacteria from your skin and hair

Nurse washing patient with Antiseptic gloves impregnated with 2% chlorhexidine digluconate to remove bacteria

Hospitals around the world are fighting against Hospital Acquired Infections (HCAIs). These type of infections, also known as nosocomial  infections, affect patients in a hospital or other healthcare facility, and are not present or incubating at the time of admission. If not treated, these infections can be life-threatening.

With the increase of invasive procedures, there are more cases of patients suffering from HCAIs. Bathing 21® is the key component in reducing transmission between care recipients, their caregivers and the  environment. It is the person-bound body wash solution

for care-dependent people. Swash® Antiseptic offers a more hygienic body wash by using person-bound, single-use products instead of a traditional bed bath with soap, water, washcloths and towels.

Swash® Antiseptic products consist of moist wash gloves, wipes or antiseptic caps that guarantee a mild antiseptic body and hair wash by releasing a constant and consistent dose of 2% Chlorhexidine Digluconate (CHG).

The rinse-free antiseptic lotion dries quickly after the application, kills harmful bacteria on the skin, and eliminates a large range of microorganisms that cause infections.

Fast acting – long lasting
The anti-bacterial process with CHG occurs rapidly, typically starts killing bacteria within 20 seconds*. Thanks to the slow release of the CHG molecules, ensures a long lasting protection against bacteria (for at least 6 hours**).

graphic bathing gloves

* McDonnell, Gerald and A. Denver Russell. “Antiseptics and Disinfectants: Activity, Action and Resistance.” Clinical Microbiology Reviews 12.1 (1999): 147-79. ** Hibbard J. Analysis comparing the anti-microbial activity and safety of current antiseptics: a review. Journal of Infusion Nursing 2005; 28(3): 194-207.

Did you know that...

approximately 30% of patients in ICU (Intensive Care Unit) acquires at least 1 health care-associated infection?

background pathogeen
body with hospital-acquired infections nosocomial infections bactericidal
Swash® antiseptic products are tested according to international standards against the common bacteria that cause HCAIs. We performed extra testing to determine the action against multi-resistant bacteria such as MRSA, VRE and Extended Spectrum Beta-Lactamase (ESBL). The results indicate that our products are effective against many different pathogens within 1 minute following DIN EN 1500:2013 requirements.

Effectiveness against various pathogens

Bactericidal (gram-positive) 
DIN EN 13727:2013

Bactericidal (gram-negative)
DIN EN 13727:2013

Yeasticidal
DIN EN 13624:2013

Bactericidal
DIN EN 1500:2013

Skin Decolonization
DIN EN 1500:2013

• Staphylococcus aureus
• Enterococcus hirae (incl. VRE)
• MRSA

• Escherichia coli
• Klebsiella pneumonia ESBL
• Pseudomonas aeruginosa

• Candida albicans

• Bactericidal in practical use


• Skin decolonization in a 5 second rub on skin poor in sebaceous glands

How the Swash®
Bathing Gloves Antiseptic work...

  • Bacterial burden present on the skin, such as MRSA, VRE and EBSL.
  • Chlorhexidine Digluconate kills a range of gram-positive and gram-negative bacteria and yeast.
  • It binds to the top layer of the skin, which results in persistent activity.
graphic wipes
Scroll to Top